Vendela Parrow joined Beactica as Head of Preclinical Biology in 2019. She received her Ph.D. in Medical Sciences, tumour biology, from Uppsala University, where she also passed her exam in Clinical Drug Development. Vendela brings extensive experience in preclinical and clinical development to Beactica. She previously held key positions at Akinion Pharmaceuticals, Axelar and Pharmacia Biovitrum; she was a cofounder, CSO and CEO of Akinion, and also Head of Facility of In Vitro and Systems Pharmacology Facility at SciLifeLab Drug Discovery and Development Platform.
Sign up for the Beactica newsletter to recieve our latest news and updates